Evaluation of Dosing and Clinical Outcomes in Patients Undergoing Conversion of Insulin Glargine to Insulin Detemir
Pharmacotherapy - United States
doi 10.1002/phar.1168
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2013
Authors
Publisher
Wiley